UNSPSC 51386016: Tenosiprol

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3E44064G8N. European Medicines Agency schedules Tenosiprol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10899MIG. Tenosiprol generally arises in the molecular formula C10H11NO4S.

UNSPSC 51386016 Tenosiprol is a Commodity code that does not align with the recent state and local procurement activity posted under it. The three recorded opportunities — a Seminole County naloxone and drug deactivation system procurement, a Texas HHS direct-to-manufacturer prescription program RFI, and a Minnesota multistate cooperative purchasing alliance generic pharmaceutical and OTC product RFP — involve naloxone, direct pharmacy benefit contracting, and generic multi-source pharmaceuticals respectively, none of which are tenosiprol-specific products or services. The code shows no recent opportunities actually soliciting tenosiprol, a prostaglandin analogue pharmaceutical used primarily in ophthalmology and critical care settings.

The mismatch suggests either a data tagging error in the state and local procurement database or that tenosiprol procurement by state and local governments is sufficiently rare that it does not generate dedicated solicitation activity under this code. The opportunities that are tagged demonstrate that state and local drug procurement predominantly occurs through cooperative purchasing vehicles (MMCAP), emergency health system procurements (Seminole County), and strategic RFI market-research processes (Texas HHS) rather than as single-product solicitations. Unless the code tagging is corrected or tenosiprol demand materializes through one of these pathways — such as inclusion in a future generic pharmaceutical cooperative bid or a specific health system need — this code does not represent a current market opportunity.